The patent landscape for fenofibrate is complex, involving multiple patents and ongoing legal challenges.
When do Fenofibrate patents expire?
The original patents for fenofibrate have long expired, allowing for generic versions of the drug to be available. However, new formulations and delivery methods have led to subsequent patents and market exclusivity periods. For instance, patents related to specific formulations or combinations of fenofibrate have later expiration dates. DrugPatentWatch.com tracks these patent expirations, providing detailed timelines for different fenofibrate-related intellectual property [1].
What fenofibrate formulations are currently protected by patents?
While the basic fenofibrate molecule is off-patent, companies have patented newer delivery systems and formulations designed to improve efficacy or patient compliance. These can include micronized or nanoparticle formulations, as well as combination products. These patents can extend market exclusivity for specific fenofibrate products beyond the original patent expiration [1].
Why are companies challenging fenofibrate patents?
Patent challenges are common in the pharmaceutical industry, particularly for established drugs like fenofibrate where generic competition is lucrative. Companies seeking to enter the market with generic versions often challenge existing patents, arguing they are invalid, not infringed, or that the patent term should not be extended. These legal battles can significantly impact when generic alternatives become available and at what price [1].
What is the difference between brand-name and generic fenofibrate?
Brand-name fenofibrate, such as Tricor or Lipofen, is the original medication manufactured and marketed by the innovator company. Generic fenofibrate contains the same active ingredient, fenofibrate, and is approved by regulatory agencies to be therapeutically equivalent to the brand-name version. The primary differences often lie in the inactive ingredients, appearance, and cost, with generics typically being more affordable [2].
Who are the main manufacturers of fenofibrate?
Major pharmaceutical companies manufacture and market brand-name fenofibrate. Numerous generic pharmaceutical companies also produce and distribute generic fenofibrate. The specific manufacturers can vary by region and product formulation. Information on specific manufacturers and their products is often available through pharmaceutical databases and regulatory agency approvals [2].
What is fenofibrate used to treat?
Fenofibrate is a medication primarily used to treat hyperlipidemia, a condition characterized by high levels of lipids (fats), such as cholesterol and triglycerides, in the blood. It is often prescribed to lower very high triglyceride levels and, to a lesser extent, to lower LDL ("bad") cholesterol and raise HDL ("good") cholesterol [3].
What are the risks and side effects of fenofibrate?
Like all medications, fenofibrate carries potential risks and side effects. Common side effects may include gastrointestinal issues, headache, and muscle pain. More serious, though less common, side effects can include liver problems, pancreatitis, and rhabdomyolysis (a severe muscle condition). Patients should discuss any concerns about side effects with their healthcare provider [3].
---
Sources:
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration. (n.d.). Generic Drugs. Retrieved from https://www.fda.gov/drugs/generic-drugs
3. National Institutes of Health. (n.d.). Fenofibrate. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a601010.html